Source: Letters in Drug Design & Discovery. Unidade: FCF
Subjects: NEOPLASIAS PULMONARES, NANOTECNOLOGIA, RESISTÊNCIA MICROBIANA ÀS DROGAS
ABNT
AWASTHI, Rajendra et al. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, v. 20, n. 5, p. 499-516, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570180819666220510133408. Acesso em: 18 nov. 2024.APA
Awasthi, R., Singh, A. K., Mishra, G., Maurya, A., Dhiman, N., Kharkwal, H., et al. (2023). Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, 20( 5), 499-516. doi:10.2174/1570180819666220510133408NLM
Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1570180819666220510133408Vancouver
Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1570180819666220510133408